Biology of natural killer cells in cancer and infection (Q34651546)

3 August 2017

1 reference

title

Biology of natural killer cells in cancer and infection (English)

1 reference

3 August 2017

Jeffrey S Miller

1

1 reference

3 August 2017

publication date

1 January 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

20

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

405-419

1 reference

Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Population dynamics of human activated natural killer cells in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Functional association of CD7 with phosphatidylinositol 3-kinase: interaction via a YEDM motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Resistance of CD7-deficient mice to lipopolysaccharide-induced shock syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Binding properties of a cell adhesion molecule from neural tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Contribution of CR3, CD11b/CD18 to cytolysis by human NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Target lysis by human lak cells is critically dependent upon target binding properties, but LFA-1, LFA-3 AND ICAM-1 are not the major adhesion ligands on targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Signaling through the LFA-1 leucocyte integrin actively regulates intercellular adhesion and tumor necrosis factor-alpha production in natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

The CD2-subset of the Ig superfamily of cell surface molecules: receptor-ligand pairs expressed by NK cells and other immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

NK and LAK activities from human marrow progenitors. I. The effects of interleukin-2 and interleukin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Response of resting human peripheral blood natural killer cells to interleukin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

A potential role for interleukin-15 in the regulation of human natural killer cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Increased release of interleukin-1 and tumour necrosis factor by interleukin-2-induced lymphokine-activated killer cells in the presence of cisplatin and FK-565

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Biology of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

In search of the 'missing self': MHC molecules and NK cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Natural killer cell receptors: the offs and ons of NK cell recognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Arousal and inhibition of human NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Ly-49-independent natural killer (NK) cell specificity revealed by NK cell clones derived from p53-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recogn

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificitie

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

The killer cell inhibitory receptor genomic region on human chromosome 19q13.4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

What goes up must come down: the emerging spectrum of inhibitory receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Killer cell inhibitory receptors: diversity, specificity, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Human diversity in killer cell inhibitory receptor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Association of DAP12 with activating CD94/NKG2C NK cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

A multigene family on human chromosome 12 encodes natural killer-cell lectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Structure of CD94 Reveals a Novel C-Type Lectin Fold

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

An activating immunoreceptor complex formed by NKG2D and DAP10

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty comple

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

The Ikaros gene is required for the development of all lymphoid lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, Id3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Involvement of transcription factors TCF-1 and GATA-3 in the initiation of the earliest step of T cell development in the thymus

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Clonal acquisition of the Ly49A NK cell receptor is dependent on the trans-acting factor TCF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Expression of CD3-zeta on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Chronic myelogenous leukemia: in search of the benign hematopoietic stem cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Evaluation of natural killer cell expansion and activation in vivo with daily subcutaneous low-dose interleukin-2 plus periodic intermediate-dose pulsing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Signal transduction during natural killer cell activation: inside the mind of a killer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Natural Killer (NK) Activity in Human Responders and Nonresponders to Stimulation by Anti-CD16 Antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Differential expression of CD8α and CD8β associated with MHC-restricted and non-MHC-restricted cytolytic effector cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

Requirement for IRF-1 in the microenvironment supporting development of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

An HMG-box-containing T-cell factor required for thymocyte differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120001185

21 January 2018

Identifiers

DOI

10.1081/CNV-120001185

1 reference

3 August 2017

1 reference